Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study

OBJECTIVES: Estimate and compare the risk of mortality in patients whose antidiabetic therapy is modified to include pioglitazone compared with an alternative antidiabetic medication at the same stage of disease progression. DESIGN: Retrospective cohort study. SETTING: Pooled analysis of clinical da...

Descripción completa

Detalles Bibliográficos
Autores principales: Strongman, Helen, Korhonen, Pasi, Williams, Rachael, Bahmanyar, Shahram, Hoti, Fabian, Christopher, Solomon, Majak, Maila, Kool-Houweling, Leanne, Linder, Marie, Dolin, Paul, Heintjes, Edith M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530248/
https://www.ncbi.nlm.nih.gov/pubmed/28761650
http://dx.doi.org/10.1136/bmjdrc-2016-000364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530248/
https://www.ncbi.nlm.nih.gov/pubmed/28761650
http://dx.doi.org/10.1136/bmjdrc-2016-000364

Ejemplares similares